Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. [Phase 1]

View source ↗

Summary

A Phase 1 study of PF-07062119 in selected advanced or metastatic gastrointestinal tumors was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Esophageal Adenocarcinoma
• Gastric Adenocarcinoma
• Gastrointestinal Neoplasms

Drugs mentioned

• PF-07062119 (PF-07062119)

Snippet

Sponsor: Pfizer | Conditions: Gastrointestinal Tumors, Colorectal Adenocarcinomas | Phase 1 | Status: TERMINATED | Results posted: 2025-01-16